Me-4(18F)DG

DB19207InvestigationalSmall molecule

Me-4(18F)DG is under investigation in clinical trial NCT05558904 (An Investigational Scan (Me-4fdg PET/CT) for the Detection of Sodium-glucose Transport for Early Diagnosis of Lung Cancer).

Mechanism: Pharmacologically active on Sodium/glucose cotransporter 2 and Sodium/glucose cotransporter 1
Curator reviewed
Formula / weight: C₇H₁₃FO₅ · 195.177 g/mol (avg)
Also known as: .alpha.-d-glucopyranoside, methyl 4-deoxy-4-(fluoro-18f)- · .alpha.-methyl-4-(F-18)-fluoro-4-deoxy-d-glucopyranoside · (2s,3r,4r,5s,6r)-5-(fluoro-18f)-6-(hydroxymethyl)-2-methoxytetrahydro-2h-pyran-3,4-diol · Alpha-methyl-4-deoxy-4-((18)f)fluoro-d-glucopyranoside
Code names: Me-4(18F)DG · Me-4FDG

Resolves to

Compound

UNII5INH2Q4NR1CAS915776-36-2

Structure

InChIKeyPGYKOSXDWWGTOB-XZWCPNKHSA-NSMILESCO[C@H]1O[C@H](CO)[C@@H]([18F])[C@H](O)[C@H]1O

Targets

P31639SLC5A2P13866SLC5A1

What you can answer from here — as of July 09, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Me-4(18F)DG, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account